Shares in Amazon ( AMZN) are up nearly 46% over the past year, with the stock hitting a record high closing price of $238.15 ...

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...

The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

Crypto is in a cooling period after running to a new record last week and was pulled lower by the DeepSeek-driven sell-off in tech stocks.

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

Finally, some good news for Novo Nordisk (NYSE: NVO) shareholders! Twice in the past two months, the Danish manufacturer of ...

Novo Nordisk stock is paring its year-over-year deficit on positive early stage trial results for the company's new weight ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Despite these results, Novo Nordisk's stock experienced a downturn, which may reflect investor concerns over the commercial implications or regulatory prospects of the new dosage. The trial outcomes ...

Novo Nordisk investors could see the news put $14.3 billion in Medicare revenue at risk. Viking Therapeutics stock, in contrast, might dodge a bullet on this news. And why? As CNBC reports today ...

Novo stock prices fell by more than 3% when the ... not to comply but still wish to sell to Medicare patients. Novo Nordisk’s position in the American market has been in a precarious place ...